In The News
Clyde & Co sued by insurers over indemnity advice
‘Our integrations are on track’: Class action flags WiseTech response to short seller report
Russells partner accused of bullying told lawyer she was ‘very negative’
Cornwalls hits back at $4.8M negligence suit by former client
Top silk to join NSW Supreme Court
NAB accused of rescinding job offer to pregnant employee
Ex-Bulldogs player must produce messages between solicitor and doctor
AI pathology invention just administrative tool, not patentable: IP Australia
Ultimate Fighting Championship gym exec not on the hook for $5M judgment
Bird & Bird snags DLA Piper partner for Sydney office
Please login to bookmarkClose

German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au